Immunicon, Kreatech Biotechnology B.V. deal

IMMC and Kreatech expanded a deal under which IMMC has rights to use Kreatech's Universal Linkage System technology to develop assays to diagnose cancer in epithelial cells (see BioCentury, Jan. 9, 20...